Dominant Malignant Clones Leverage Lineage Restricted Epigenomic Programs to Drive Ependymoma Development.
Kardian A, Sun H, Ippagunta S, Laboe N, Chen HC, Emanus E, Varadharajan S, Zheng T, Holcomb B, Connelly P, Connelly JP, Wang M, Lowe K, Pruett-Miller SM, Bertrand KC, Deneen B, Mack SC.
Kardian A, et al. Among authors: connelly p.
bioRxiv [Preprint]. 2024 Aug 15:2024.08.12.607603. doi: 10.1101/2024.08.12.607603.
bioRxiv. 2024.
PMID: 39211123
Free PMC article.
Preprint.